New hope for advanced lung cancer patients with no options left
NCT ID NCT07423169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment for people with advanced lung cancer that cannot be removed by surgery. It combines a special type of radiation that targets only the center of the tumor with an immunotherapy drug that was used before. The goal is to see if this combination can slow down the cancer better than the immunotherapy alone. About 10 adults who have run out of standard treatment options will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BULKY TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radiation Oncology Department
RECRUITINGKrems, Austria, 3500, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI be a Pathologist's second opinion?
- Blood tests could unlock early clues for three major lung diseases
- New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
- Why some Never-Smokers get lung cancer: a new study investigates
- Could an asthma drug help fight lung cancer? early trial investigates
- Vaccine trains immune system to hunt down cancer cells